New blood tests for hepatitis B
Part of Cancer, Digestive system, Infections clinical trials.
This study looks at new blood tests (biomarkers) to better understand chronic hepatitis B and how it affects treatment decisions. It may help doctors find better ways to manage your condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have chronic hepatitis B (been infected for more than 6 months).
- You are receiving care at the Henri Mondor-Albert Chenevier University Hospital group.
- You have not had a liver transplant due to hepatitis B.
- You can legally consent to participate.
- You are not pregnant or breastfeeding.
- You have French health insurance (Social Security).
- You agree to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who have chronic hepatitis B and are seeing a liver specialist for the first time. It aims to track the disease and improve care.
This study is testing a new blood test that measures the amount of hepatitis B virus (HBV) in your body. It helps see if the test works as well as current approved tests.
This study builds a group of people to measure small hepatitis B “viral RNA” signals in the blood. The goal is to see if these measurements could help researchers find a functional cure and better understand who may respond over time.
This study looks at the genes of people with chronic hepatitis B (HBV) to find why some people's immune cells (B cells and NK cells) stop working properly. The goal is to discover new ways to treat the disease.
This study collects a small sample of liver cells to understand how hepatitis B virus behaves in the liver and how the immune system responds. This could help improve future treatments for chronic hepatitis B.
This study looks at how treating chronic hepatitis B affects people's daily lives, not just their liver health. It aims to understand the good and bad impacts from a patient's perspective.
Hear when a new Chronic Hepatitis B Virus (HBV) Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.